Common Stock, Shares, Outstanding of KIORA PHARMACEUTICALS INC from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
KIORA PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • KIORA PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 3,433,491, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

KIORA PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 3,433,491 +432,703 +14% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 3,433,491 +462,946 +16% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 3,000,788 -23,255,409 -89% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 3,000,788 +2,144,606 +250% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 3,000,788 -4,688,452 -61% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 2,970,545 -3,940,175 -57% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 26,256,197 +24,336,927 +1268% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 856,182 -940,290 -52% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 7,689,240 +6,610,195 +613% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 6,910,720 -6,156,706 -47% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 1,919,270 -10,744,695 -85% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 1,796,472 +1,479,873 +467% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 1,079,045 -11,540,211 -91% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 13,067,426 +5,969,514 +84% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 12,663,965 +5,566,053 +78% 31 Mar 2022 10-Q 08 Jul 2022 2022 Q1
Q4 2021 316,599 -5,239,795 -94% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 12,619,256 +7,992,501 +173% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 7,097,912 +2,471,157 +53% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 7,097,912 +2,471,157 +53% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 5,556,394 +1,478,639 +36% 31 Dec 2020 10-K/A 07 Jul 2022 2021 FY
Q3 2020 4,626,755 +1,590,295 +52% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 4,626,755 -41,048,982 -90% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 4,626,755 -40,948,982 -90% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 4,077,755 +1,039,163 +34% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 3,036,460 -40,407,670 -93% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 45,675,737 +3,292,857 +7.8% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 45,575,737 +28,318,482 +164% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 3,038,592 -14,218,663 -82% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 43,444,130 +26,239,352 +153% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 42,382,880 +25,178,102 +146% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 17,257,255 +6,379,139 +59% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 17,257,255 +7,126,372 +70% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 17,204,778 +7,618,895 +79% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 17,204,778 +8,252,895 +92% 30 Jun 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 10,878,116 +2,531,672 +30% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 10,130,883 +2,473,596 +32% 31 Dec 2016 10-K 02 Mar 2018 2017 FY
Q3 2016 9,585,883 +1,931,239 +25% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 8,951,883 +2,474,790 +38% 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 8,346,444 +1,994,746 +31% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 7,657,287 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 7,654,644 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 6,477,093 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 6,351,698 31 Mar 2015 10-Q 18 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.